tetano
Editor, Senior Moderator
Clin Infect Dis
. 2020 Jul 16;ciaa992.
doi: 10.1093/cid/ciaa992. Online ahead of print.
Long-term outcome of short-course high-dose glucocorticoids for SARS: a 17-year follow-up in SARS survivors
Chor-Wing Sing[SUP] 1 [/SUP], Kathryn C B Tan[SUP] 2 [/SUP], Ian C K Wong[SUP] 1 3 [/SUP], Bernard M Y Cheung[SUP] 2 [/SUP], Ching-Lung Cheung[SUP] 1 [/SUP]
Affiliations
Abstract
Use of high-dose glucocorticoids for coronavirus disease 2019 (COVID-19; caused by SARS-CoV-2) is controversial because of safety concerns. We examined long-term consequences in severe acute respiratory syndrome (SARS; caused by SARS-CoV-1) survivors. Results showed that high-dose glucocorticoids greatly increased long-term risk of avascular necrosis, but not other major diseases.
. 2020 Jul 16;ciaa992.
doi: 10.1093/cid/ciaa992. Online ahead of print.
Long-term outcome of short-course high-dose glucocorticoids for SARS: a 17-year follow-up in SARS survivors
Chor-Wing Sing[SUP] 1 [/SUP], Kathryn C B Tan[SUP] 2 [/SUP], Ian C K Wong[SUP] 1 3 [/SUP], Bernard M Y Cheung[SUP] 2 [/SUP], Ching-Lung Cheung[SUP] 1 [/SUP]
Affiliations
- PMID: 32671407
- DOI: 10.1093/cid/ciaa992
Abstract
Use of high-dose glucocorticoids for coronavirus disease 2019 (COVID-19; caused by SARS-CoV-2) is controversial because of safety concerns. We examined long-term consequences in severe acute respiratory syndrome (SARS; caused by SARS-CoV-1) survivors. Results showed that high-dose glucocorticoids greatly increased long-term risk of avascular necrosis, but not other major diseases.